Related Experiment Video
Updated: Feb 9, 2026

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
Published on: April 9, 2019
Strategies for targeting the androgen receptor axis in prostate cancer
1Department of Surgery, Division of Urology and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Abstract:
Androgen receptor (AR) signaling plays a critical role in prostate cancer cell proliferation, survival, and differentiation. Therapeutic strategies targeting the androgen receptor have been developed for the treatment of metastatic hormone-naïve prostate cancer; however, despite effective targeting recent studies have demonstrated that during progression to a castrate-resistant phenotype there is restoration of AR target gene expression. On the basis of this observation, second-generation therapeutics have been developed to target AR in the castrate-resistant setting resulting in a survival benefit. In this review we will discuss the mechanisms promoting AR signaling and the development of second-generation therapeutics targeting AR in castrate-resistant prostate cancer.
Insights
Androgen receptor (AR) signaling is key in prostate cancer. New therapies target AR in castrate-resistant prostate cancer, showing improved survival by restoring AR signaling pathways.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Androgen receptor (AR) signaling is crucial for prostate cancer progression.
- Metastatic hormone-naïve prostate cancer treatments target AR effectively.
- AR signaling is restored during progression to castrate-resistant prostate cancer.
Purpose of the Study:
- To review mechanisms driving AR signaling in prostate cancer.
- To discuss the development of second-generation therapeutics targeting AR.
- To highlight AR-targeted therapies for castrate-resistant prostate cancer.
Main Methods:
- Literature review of studies on AR signaling in prostate cancer.
- Analysis of mechanisms promoting AR signaling.
- Overview of second-generation AR-targeted therapeutics.
Main Results:
- AR signaling restoration occurs during castrate-resistant prostate cancer development.
- Second-generation therapeutics targeting AR show survival benefits.
- Understanding AR signaling mechanisms is vital for treatment development.
Conclusions:
- Targeting AR signaling is a critical strategy for prostate cancer treatment.
- Second-generation AR-targeted therapies offer improved outcomes in castrate-resistant disease.
- Further research into AR signaling mechanisms can lead to novel therapeutic approaches.
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Related Concept Videos
Internal Receptors
Targeted Cancer Therapies
There are several types of targeted therapies against...
Hypothalamic-Pituitary Axis
Perpendicular-Axis Theorem
Consider a circular disc of mass M and radius R lying along an x-y plane. The origin lies at the center of the disc, and the z-axis is perpendicular to the disc's plane. All three axes coincide at the disc's center. The moment of inertia of this...
Parallel-axis Theorem
Moment of a Force About an Axis: Scalar
To better understand the concept of moment of force, consider the example of a cyclist riding a bicycle. When the cyclist applies force on...